Literature DB >> 8834339

Interaction between calcium, neutral endopeptidase and the substance P mediated ciliary response in human respiratory epithelium.

R P Smith1, R Shellard, G Di Benedetto, C J Magnus, A Mehta.   

Abstract

Following irritation of the airway, the ciliostimulatory effects of the tachykinin, substance P (SP), are thought to be secondary to mucus release. We hypothesized that SP also induces small increases in ciliary beat frequency (CBF) via a calcium-mediated process. Brushed ciliated cells from the nasal epithelium of healthy human subjects were suspended in tissue culture fluid and the acute effects of SP upon these cells were studied in a mucus-free environment. In some preparations, changes in CBF in response to SP were measured with a video-based system. The effect of an SP antagonist, of Ca2+ channel block with verapamil, and of the calcium analogue lanthanum on the SP response were also tested. In other preparations, the ciliated cells were preloaded with Fura-2, a dye which fluoresces with Ca2+ ions, and the response of intracellular Ca2+ to SP was monitored. SP (10(-9)-10(-6) M) transiently increased CBF in a dose-dependent manner, with the maximal response occurring at 10 min. The response was small, with a maximum increase of 8.9%. The SP receptor antagonist (D-pro2,D-trp7,9)-SP (10(-5) M) abolished this effect. Verapamil (10(-5) M) attenuated the response to SP (10(-7) M), whilst lanthanum chloride (250 microM) abolished it. Inhibition of SP destruction by phosphoramidon (10(-6) M) also eliminated the transient rise in CBF. However, compared to SP alone, the combination of SP and phosphoramidon induced a novel delayed lanthanum-sensitive rise in CBF. In other experiments, SP (10(-7) M) induced a transient increase in free intracellular Ca2+ concentration (maximal rise 73%), which returned to baseline before the expected onset of the CBF response. We conclude that substance P induces either a transient or sustained increase in CBF dependent on the rate of destruction of this peptide around tachykinin receptors. These receptors are likely to be linked to lanthanum- and verapamil-sensitive pathways for the entry of Ca2+ into cells. The small magnitude of the rise in CBF makes its physiological role uncertain at present.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8834339     DOI: 10.1183/09031936.96.09010086

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Asymmetric interactions between phosphorylation pathways regulating ciliary beat frequency in human nasal respiratory epithelium in vitro.

Authors:  R P Smith; R Shellard; D P Dhillon; J Winter; A Mehta
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

2.  Functional short- and long-term effects of nasal CPAP with and without humidification on the ciliary function of the nasal respiratory epithelium.

Authors:  J Ulrich Sommer; Marius Kraus; Richard Birk; Johannes D Schultz; Karl Hörmann; Boris A Stuck
Journal:  Sleep Breath       Date:  2013-05-09       Impact factor: 2.816

3.  Mode of Ca2+ action on ciliary beat frequency in single ovine airway epithelial cells.

Authors:  M Salathe; R J Bookman
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

4.  In vivo and in vitro observation of nasal ciliary motion in a guinea pig model.

Authors:  Chuan Pang; Fengwei An; Shiming Yang; Ning Yu; Daishi Chen; Lei Chen
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-20

5.  Mycoplasma hyopneumoniae surface-associated proteases cleave bradykinin, substance P, neurokinin A and neuropeptide Y.

Authors:  Veronica Maria Jarocki; Benjamin Bernard Armando Raymond; Jessica Leigh Tacchi; Matthew Paul Padula; Steven Philip Djordjevic
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

6.  Resting tension affects eNOS activity in a calcium-dependent way in airways.

Authors:  Eudoxia Kitsiopoulou; Apostolia A Hatziefthimiou; Konstantinos I Gourgoulianis; Paschalis-Adam Molyvdas
Journal:  Mediators Inflamm       Date:  2007-03-28       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.